Contemporary coronary drug-eluting and coated stents: a mini-review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bangalore S, Toklu B, Patel N, Feit F, Stone GW. Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease. Circulation. 2018;138:2216–26.
Iannaccone M, Gatti P, Barbero U, Bassignana A, Gallo D, de Benedictis M, et al. Impact of strut thickness and number of crown and connectors on clinical outcomes on patients treated with second-generation drug eluting stent. Catheter Cardiovasc Interv. 2019. https://doi.org/10.1002/ccd.28228.
Nakazawa G, Shinke T, Ijichi T, Matsumoto D, Otake H, Torii S, et al. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model. EuroIntervention. 2014;10:717–23.
El-Hayek G, Bangalore S, Casso Dominguez A, Devireddy C, Jaber W, Kumar G, et al. Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents. JACC Cardiovasc Interv. 2017;10:462–73.
Kobayashi T, Sotomi Y, Suzuki S, Suwannasom P, Nakatani S, Morino Y, et al. Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials. Cardiovasc Interv Ther. 2020;35:250–8.
Saito S, Krucoff MW, Nakamura S, Mehran R, Maehara A, Al-Khalidi HR, et al. Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. Eur Heart J. 2018;39:2460–8.